Shasha Fan
Changsha, 410002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
WDR4 is a Potential Indicator of Clinical Diagnostics, Prognosis, and Immunotherapy in Hepatocellular Carcinoma (HCC).
Journal: Frontiers in bioscience (Landmark edition)
Published: August 13, 2025
Survival benefit of radiotherapy in pancreatic cancer A real-world analysis based on SEER and an independent hospital-based cohort.
Journal: International journal of surgery (London, England)
Published: July 10, 2025
One- and two-year overall survival following stereotactic body radiotherapy versus conventional radiotherapy for pancreatic cancer: a systematic review and meta-analysis.
Journal: International journal of surgery (London, England)
Published: June 03, 2025
Fumarate hydratase-deficient renal cell carcinoma with sarcomatoid features: a case report.
Journal: AME case reports
Published: February 07, 2025
Anemarchalconyn, a natural alkyne ketone compound, inhibits HCC cell growth by suppressing Polθ and inducing synthetic lethality in Homologous recombination deficiency cells.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: December 24, 2024
Retraction Note: TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway.
Journal: Molecular and cellular biochemistry
Published: April 24, 2024
Predictive value of thrombin-antithrombin III complex and tissue plasminogen activator-inhibitor complex biomarkers in assessing the severity of early-stage acute pancreatitis.
Journal: Journal of gastroenterology and hepatology
Published: February 28, 2024
Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma.
Journal: Cancer cell international
Published: May 07, 2023
Propensity score matching analysis to comparing cisplatin versus nedaplatin based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer.
Journal: Scientific reports
Published: March 14, 2023
ZNF655 promotes the progression of hepatocellular carcinoma through PSMB8.
Journal: Cell biology international
Published: June 20, 2022
CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma.
Journal: Cancer cell international
Published: May 30, 2022
Last Updated: 09/26/2026